Plasma YKL-40 and total and disease-specific mortality in the general population.

@article{Johansen2010PlasmaYA,
  title={Plasma YKL-40 and total and disease-specific mortality in the general population.},
  author={Julia Sidenius Johansen and Stig Egil Bojesen and Anne Tybjaerg-Hansen and Anne K{\ae}rsgaard Mylin and Paul A. Price and B\orge G. Nordestgaard},
  journal={Clinical chemistry},
  year={2010},
  volume={56 10},
  pages={1580-91}
}
BACKGROUND Increased plasma YKL-40 is associated with short-term survival in patients with cardiovascular disease and cancer. We tested the hypothesis that increased plasma YKL-40 is associated with total and disease-specific mortality in the general population. METHODS We measured plasma YKL-40 in 8899 study participants, aged 20-95 years, in the Copenhagen City Heart Study from the Danish general population who were followed for 16 years: 3059 died, 2158 had ischemic cardiovascular disease… CONTINUE READING

From This Paper

Figures, tables, and topics from this paper.

Citations

Publications citing this paper.
Showing 1-10 of 26 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 34 references

C - reactive protein and all - cause mortality : the Copenhagen City Heart Study

J Zacho, A Tybjærg-Hansen, BG Nordestgaard
Eur Heart J • 2010

a new WHO standard

OB Ahmad, C Boschi-Pinte, +3 authors rates Inoue M. Age standardization of
www.who.int/entity/ healthinfo/paper31.pdf • 2010

Extreme lipoprotein(a) levels and risk of myocardial infarction in the general population

PR Kamstrup, M Benn, A Tybjærg-Hansen, BG. Nordestgaard
The Copenhagen City Heart Study. Circulation • 2008

Similar Papers

Loading similar papers…